NCT03742661View on ClinicalTrials.gov

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 2, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2026

Conditions
Epilepsy
Interventions
DEVICE

SPEAC System

Surface Electromyography (sEMG) based seizure monitoring and alerting system

Trial Locations (1)

40502

Lexington VA Medical Center, Lexington

Sponsors

Lead Sponsor

Brain Sentinel
All Listed Sponsors
lead

Brain Sentinel

OTHER

NCT03742661 - Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis | Biotech Hunter | Biotech Hunter